Jazz Pharmaceuticals
JAZZ
#1899
Rank
โ‚ฌ8.85 B
Marketcap
145,76ย โ‚ฌ
Share price
1.67%
Change (1 day)
25.86%
Change (1 year)

Revenue for Jazz Pharmaceuticals (JAZZ)

Revenue in 2025 (TTM): โ‚ฌ3.72 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ3.57 Billion. In 2024 the company made a revenue of โ‚ฌ3.91 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ3.46 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Jazz Pharmaceuticals from 2005 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ3.72 B-4.8%
2024 โ‚ฌ3.91 B12.74%
2023 โ‚ฌ3.46 B1.67%
2022 โ‚ฌ3.41 B24.86%
2021 โ‚ฌ2.73 B42.18%
2020 โ‚ฌ1.92 B-0.42%
2019 โ‚ฌ1.92 B16.75%
2018 โ‚ฌ1.65 B22.52%
2017 โ‚ฌ1.34 B-4.63%
2016 โ‚ฌ1.41 B16.75%
2015 โ‚ฌ1.21 B25.64%
2014 โ‚ฌ0.96 B52.66%
2013 โ‚ฌ0.63 B42.6%
2012 โ‚ฌ0.44 B111.29%
2011 โ‚ฌ0.20 B60.48%
2010 โ‚ฌ0.13 B45.73%
2009 โ‚ฌ89.65 M85.65%
2008 โ‚ฌ48.29 M7.98%
2007 โ‚ฌ44.72 M31.56%
2006 โ‚ฌ33.99 M87.8%
2005 โ‚ฌ18.1 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Endo International
ENDPQ
โ‚ฌ1.72 B-51.62%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
โ‚ฌ218.52 B 6,019.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.41 B 1,255.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.40 B 303.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel